Find policies, billing codes, payers, states, and providers
HCPCS H0010: Sub-Acute Residential Detoxification Services
HCPCS Level II code H0010 designates sub-acute detoxification services delivered in a residential addiction program. This code captures medically supervised withdrawal management provided in a non-acute inpatient residential setting and is used to bill for structured, residential care focused on stabilizing patients with substance use disorders during detox. The code is nationally relevant as residential detoxification remains a critical component of the continuum of care for substance use disorders and aligns billing with appropriate care settings.
Payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find an overview of where H0010 fits in the detoxification and addiction treatment taxonomy, how it relates to alternative detox and treatment codes, typical clinical indications associated with residential detox, and the common contexts in which the code is billed. The publication summarizes benchmarking considerations, payer coverage patterns, and clinical context relevant to utilization of residential sub-acute detoxification services.
The piece is intended for healthcare policy analysts, billing professionals, and clinical leaders seeking a concise national-level reference on H0010, its clinical role, related billing combinations, and the payer landscape that commonly reimburses residential detox services.
Customize your policy alerts
Sign up for hcpcs H0010 policy alerts
Get alerted when payer policies referencing H0010 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code H0010 represents alcohol and/or drug services for sub-acute detoxification provided in a residential addiction program. The service is a sub-acute detoxification intervention focused on medically monitored withdrawal management without the intensity of acute inpatient detox. Typical site of service is a residential addiction program (inpatient residential setting) where patients receive structured monitoring, supportive care, and clinical oversight during detoxification.
National Reimbursement Benchmarks
National commercial benchmark (BUCA) centers near $199.30 for HCPCS H0010, placing it in the mid-range of payer distributions. Among named commercial plans, Cigna shows a high central tendency with a median of $516.60 and a concentrated upper distribution; Blue Cross Blue Shield (BCBS) and Aetna display broader spreads and lower medians compared with Cigna. UnitedHealth Group sits at the low end with a median of $48.50 and a tighter low-rate cluster.
Examining dispersion (P75 minus P25) highlights who is tightest and widest: Cigna’s P75–P25 spread is $372.30 (from $144.30 to $516.60), BCBS’s spread is $145.80 (from $134.10 to $279.90), BUCA’s spread is $149.40 (from $116.50 to $265.90), Aetna’s spread is $63.60 (from $120.00 to $183.60), and UnitedHealth Group has the tightest spread at $22.80 (from $32.50 to $55.30). These differences indicate notable variability in upper-tail pricing across payers.